• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对神经炎症的 SCA3 的病理机制特征描述和潜在治疗方法的鉴定。

Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.

机构信息

Department of Life Science, National Taiwan Normal University, Taipei 11677, Taiwan.

Department of Neurology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 33302, Taiwan.

出版信息

Aging (Albany NY). 2020 Nov 10;12(23):23619-23646. doi: 10.18632/aging.103700.

DOI:10.18632/aging.103700
PMID:33196459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762503/
Abstract

Polyglutamine (polyQ)-mediated spinocerebellar ataxias (SCA) are caused by mutant genes with expanded CAG repeats encoding polyQ tracts. The misfolding and aggregation of polyQ proteins result in increased reactive oxygen species (ROS) and cellular toxicity. Inflammation is a common manifestation of oxidative stress and inflammatory process further reduces cellular antioxidant capacity. Increase of activated microglia in the pons of SCA type 3 (SCA3) patients suggests the involvement of neuroinflammation in the disease pathogenesis. In this study, we evaluated the anti-inflammatory potentials of indole compound NC009-1, 4-aminophenol-arachidonic acid derivative AM404, quinoline compound VB-037 and chalcone-coumarin derivative LM-031 using human HMC3 microglia and SCA3 ATXN3/Q-GFP SH-SY5Y cells. The four tested compounds displayed anti-inflammatory activity by suppressing NO, IL-1β, TNF-α and IL-6 production and CD68 expression of IFN-γ-activated HMC3 microglia. In retinoic acid-differentiated ATXN3/Q-GFP SH-SY5Y cells inflamed with IFN-γ-primed HMC3 conditioned medium, treatment with the tested compounds mitigated the increased caspase 1 activity and lactate dehydrogenase release, reduced polyQ aggregation and ROS and/or promoted neurite outgrowth. Examination of IL-1β- and TNF-α-mediated signaling pathways revealed that the tested compounds decreased IκBα/P65, JNK/JUN and/or P38/STAT1 signaling. The study results suggest the potential of NC009-1, AM404, VB-037 and LM-031 in treating SCA3 and probable other polyQ diseases.

摘要

多聚谷氨酰胺(polyQ)介导的脊髓小脑共济失调(SCA)是由编码多聚 Q 片段的突变基因引起的,这些基因的 CAG 重复序列扩展。多聚 Q 蛋白的错误折叠和聚集导致活性氧(ROS)和细胞毒性增加。炎症是氧化应激和炎症过程的常见表现,进一步降低了细胞的抗氧化能力。SCA 3 型(SCA3)患者桥脑部位激活的小胶质细胞增加表明神经炎症参与了疾病的发病机制。在这项研究中,我们使用人 HMC3 小胶质细胞和 SCA3 ATXN3/Q-GFP SH-SY5Y 细胞评估了吲哚化合物 NC009-1、4-氨基苯酚-花生四烯酸衍生物 AM404、喹啉化合物 VB-037 和查尔酮-香豆素衍生物 LM-031 的抗炎潜力。四种测试化合物通过抑制 NO、IL-1β、TNF-α 和 IFN-γ 激活的 HMC3 小胶质细胞产生的 IL-6 以及 CD68 表达显示出抗炎活性。在 IFN-γ 预刺激的 HMC3 条件培养基诱导的分化的 ATXN3/Q-GFP SH-SY5Y 细胞中,用测试化合物处理减轻了 caspase 1 活性和乳酸脱氢酶释放的增加,减少了多聚 Q 聚集和 ROS,或促进了神经元突起的生长。对 IL-1β 和 TNF-α 介导的信号通路的检测表明,测试化合物降低了 IκBα/P65、JNK/JUN 和/或 P38/STAT1 信号。研究结果表明,NC009-1、AM404、VB-037 和 LM-031 具有治疗 SCA3 和其他可能的多聚 Q 疾病的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/93bef563e439/aging-12-103700-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/34a4cc334abc/aging-12-103700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/923746bb9ef0/aging-12-103700-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/f8a232745557/aging-12-103700-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/e0544047967f/aging-12-103700-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/03332d6d311e/aging-12-103700-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/12ab927dddf1/aging-12-103700-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/c083e17ac9b9/aging-12-103700-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/93bef563e439/aging-12-103700-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/34a4cc334abc/aging-12-103700-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/923746bb9ef0/aging-12-103700-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/f8a232745557/aging-12-103700-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/e0544047967f/aging-12-103700-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/03332d6d311e/aging-12-103700-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/12ab927dddf1/aging-12-103700-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/c083e17ac9b9/aging-12-103700-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc79/7762503/93bef563e439/aging-12-103700-g008.jpg

相似文献

1
Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.针对神经炎症的 SCA3 的病理机制特征描述和潜在治疗方法的鉴定。
Aging (Albany NY). 2020 Nov 10;12(23):23619-23646. doi: 10.18632/aging.103700.
2
Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1β and IL-6 signaling pathways in spinocerebellar ataxia type 3.研究靶向脊髓小脑共济失调 3 型炎症性白细胞介素-1β和白细胞介素-6 信号通路的新型化合物的治疗效果。
Eur J Pharmacol. 2024 Mar 15;967:176370. doi: 10.1016/j.ejphar.2024.176370. Epub 2024 Feb 5.
3
Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.针对神经炎症的帕金森病的病理机制特征分析及潜在治疗药物的鉴定。
Int J Mol Sci. 2021 Jan 21;22(3):1062. doi: 10.3390/ijms22031062.
4
Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3.小分子通过与突变 ATXN3 和 LC3 相互作用诱导扩张多聚谷氨酰胺蛋白的自噬降解。
Int J Mol Sci. 2024 Oct 4;25(19):10707. doi: 10.3390/ijms251910707.
5
The potential of indole and a synthetic derivative for polyQ aggregation reduction by enhancement of the chaperone and autophagy systems.吲哚及其合成衍生物通过增强伴侣蛋白和自噬系统减少多聚谷氨酰胺聚集的潜力。
ACS Chem Neurosci. 2014 Oct 15;5(10):1063-74. doi: 10.1021/cn500075u. Epub 2014 Sep 19.
6
Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against α-synuclein toxicity.香豆素-查尔酮杂合体 LM-021 和吲哚衍生物 NC009-1 靶向炎症和氧化应激,以保护 BE(2)-M17 细胞免受α-突触核蛋白毒性的影响。
Aging (Albany NY). 2023 Aug 11;15(16):8061-8089. doi: 10.18632/aging.204954.
7
Aqueous extract of Glycyrrhiza inflata inhibits aggregation by upregulating PPARGC1A and NFE2L2-ARE pathways in cell models of spinocerebellar ataxia 3.胀果甘草水提取物通过上调脊髓小脑共济失调3型细胞模型中的PPARGC1A和NFE2L2-ARE通路来抑制聚集。
Free Radic Biol Med. 2014 Jun;71:339-350. doi: 10.1016/j.freeradbiomed.2014.03.023. Epub 2014 Mar 25.
8
Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.以中药靶向泛素蛋白酶体通路治疗脊髓小脑性共济失调 3 型。
Am J Chin Med. 2019;47(1):63-95. doi: 10.1142/S0192415X19500046. Epub 2019 Jan 7.
9
Aqueous extract of Gardenia jasminoides targeting oxidative stress to reduce polyQ aggregation in cell models of spinocerebellar ataxia 3.栀子水提取物靶向氧化应激以减少脊髓小脑共济失调3型细胞模型中的多聚谷氨酰胺聚集。
Neuropharmacology. 2014 Jun;81:166-75. doi: 10.1016/j.neuropharm.2014.01.032. Epub 2014 Jan 31.
10
Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.药物基因组筛选鉴定出 ATXN3(脊髓小脑共济失调 3 型疾病蛋白)丰度和毒性的新调节剂。
Neurobiol Dis. 2020 Apr;137:104697. doi: 10.1016/j.nbd.2019.104697. Epub 2019 Nov 26.

引用本文的文献

1
Die Hard: Necroptosis and its Impact on Age-Dependent Neuroinflammatory Diseases.《虎胆龙威:坏死性凋亡及其对年龄依赖性神经炎症性疾病的影响》
Front Cell Death. 2024;3. doi: 10.3389/fceld.2024.1348153. Epub 2024 Mar 8.
2
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model.ataxin1中扩展的聚谷氨酰胺导致功能丧失,加重了实验性自身免疫性脑脊髓炎小鼠模型中多发性硬化症的严重程度。
Res Sq. 2025 Apr 14:rs.3.rs-5664390. doi: 10.21203/rs.3.rs-5664390/v1.
3
An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model.

本文引用的文献

1
Exploration of multi-target effects of 3-benzoyl-5-hydroxychromen-2-one in Alzheimer's disease cell and mouse models.3-苯甲酰-5-羟基色原酮在阿尔茨海默病细胞和小鼠模型中的多靶点作用研究。
Aging Cell. 2020 Jul;19(7):e13169. doi: 10.1111/acel.13169. Epub 2020 Jun 4.
2
The Role of Microglia and Astrocytes in Huntington's Disease.小胶质细胞和星形胶质细胞在亨廷顿舞蹈病中的作用
Front Mol Neurosci. 2019 Oct 25;12:258. doi: 10.3389/fnmol.2019.00258. eCollection 2019.
3
Pathogenesis of SCA3 and implications for other polyglutamine diseases.
ataxin1 中多聚谷氨酰胺的扩增导致功能丧失,加重了实验性自身免疫性脑脊髓炎小鼠模型中多发性硬化症的严重程度。
J Neuroinflammation. 2025 Apr 30;22(1):127. doi: 10.1186/s12974-025-03450-2.
4
Associations between CAG repeat size, brain and spinal cord volume loss, and motor symptoms in spinocerebellar ataxia type 3: a cohort study.3型脊髓小脑共济失调中CAG重复序列长度、脑和脊髓体积丢失与运动症状之间的关联:一项队列研究
Orphanet J Rare Dis. 2025 Jan 23;20(1):35. doi: 10.1186/s13023-025-03531-8.
5
Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3.小分子通过与突变 ATXN3 和 LC3 相互作用诱导扩张多聚谷氨酰胺蛋白的自噬降解。
Int J Mol Sci. 2024 Oct 4;25(19):10707. doi: 10.3390/ijms251910707.
6
Altered Metabolic Signaling and Potential Therapies in Polyglutamine Diseases.多聚谷氨酰胺疾病中代谢信号的改变及潜在治疗方法
Metabolites. 2024 May 31;14(6):320. doi: 10.3390/metabo14060320.
7
Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson's Disease.研究吲哚衍生物在神经毒素诱导的帕金森病细胞和小鼠模型中靶向炎症和氧化应激的治疗效果。
Int J Mol Sci. 2023 Jan 30;24(3):2642. doi: 10.3390/ijms24032642.
8
New models of Parkinson's like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors.人类小胶质细胞克隆3中帕金森氏症样神经炎症的新模型:IFN-γ加高糖和线粒体抑制剂诱导的激活谱
Front Cell Neurosci. 2022 Nov 29;16:1038721. doi: 10.3389/fncel.2022.1038721. eCollection 2022.
9
Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases.白细胞端粒长度变异性作为多聚谷氨酰胺疾病患者的潜在生物标志物
Antioxidants (Basel). 2022 Jul 24;11(8):1436. doi: 10.3390/antiox11081436.
10
Metabolomics Signature and Potential Application of Serum Polyunsaturated Fatty Acids Metabolism in Patients With Vitiligo.代谢组学特征及血清多不饱和脂肪酸代谢在白癜风患者中的潜在应用。
Front Immunol. 2022 Feb 10;13:839167. doi: 10.3389/fimmu.2022.839167. eCollection 2022.
SCA3 的发病机制及对其他多聚谷氨酰胺疾病的影响。
Neurobiol Dis. 2020 Feb;134:104635. doi: 10.1016/j.nbd.2019.104635. Epub 2019 Oct 24.
4
Novel compound VB-037 inhibits Aβ aggregation and promotes neurite outgrowth through enhancement of HSP27 and reduction of P38 and JNK-mediated inflammation in cell models for Alzheimer's disease.新型化合物 VB-037 通过增强 HSP27 和减少 P38 和 JNK 介导的炎症,抑制 Aβ 聚集并促进神经突生长,用于阿尔茨海默病的细胞模型。
Neurochem Int. 2019 May;125:175-186. doi: 10.1016/j.neuint.2019.01.021. Epub 2019 Jan 29.
5
Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer's Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement.吲哚化合物 NC009-1 增强阿尔茨海默病细胞和小鼠模型中的 APOE 和 TRKA,实现神经保护和认知改善。
J Alzheimers Dis. 2019;67(2):737-756. doi: 10.3233/JAD-180643.
6
Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.以中药靶向泛素蛋白酶体通路治疗脊髓小脑性共济失调 3 型。
Am J Chin Med. 2019;47(1):63-95. doi: 10.1142/S0192415X19500046. Epub 2019 Jan 7.
7
Novel synthetic chalcone-coumarin hybrid for Aβ aggregation reduction, antioxidation, and neuroprotection.新型合成查尔酮-香豆素杂合体可减少 Aβ 聚集、抗氧化和神经保护。
CNS Neurosci Ther. 2018 Dec;24(12):1286-1298. doi: 10.1111/cns.13058. Epub 2018 Sep 14.
8
Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.慢性低剂量 AM404 可改善高血糖 3xTg-AD 小鼠的认知障碍和病理特征。
Psychopharmacology (Berl). 2019 Feb;236(2):763-773. doi: 10.1007/s00213-018-5108-0. Epub 2018 Nov 13.
9
The indole compound NC009-1 inhibits aggregation and promotes neurite outgrowth through enhancement of HSPB1 in SCA17 cells and ameliorates the behavioral deficits in SCA17 mice.吲哚化合物 NC009-1 通过增强 SCA17 细胞中的 HSPB1 抑制聚集并促进神经突生长,并改善 SCA17 小鼠的行为缺陷。
Neurotoxicology. 2018 Jul;67:259-269. doi: 10.1016/j.neuro.2018.06.009. Epub 2018 Jun 21.
10
The small heat shock proteins, especially HspB4 and HspB5 are promising protectants in neurodegenerative diseases.小分子热休克蛋白,特别是 HspB4 和 HspB5,是神经退行性疾病中很有前途的保护剂。
Neurochem Int. 2018 May;115:69-79. doi: 10.1016/j.neuint.2018.02.006. Epub 2018 Feb 7.